Daprodustat and Heart Failure in CKD.
Jonathan W CunninghamBrian L ClaggettRenato Deláscio LopesJohn Joseph Valentine McMurrayVlado PerkovicKevin J CarrollThomas HiemstraKaivan KhavandiMary Ann LukasPrerna RanganathanJennifer ShannonJanet van AdelsbergAjay K SinghScott D SolomonPublished in: Journal of the American Society of Nephrology : JASN (2024)
A greater number of first heart failure hospitalization events occurred in patients treated with daprodustat compared with conventional ESA, but this difference did not reach statistical significance. Differences in the number of heart failure hospitalization events were most apparent in patients not receiving dialysis and in patients with history of heart failure.